YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
FORT WORTH, Texas, October 08, 2026--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results for the third quarter 2…
In the recent past, Omnicell reported quarterly revenue of US$312.2 million, a 7.4% year-on-year increase that slightly exceeded analysts' expectations, while issuing EBITDA guidance for the next quarter that fell well short of market fore…
1 Healthcare Stock with Exciting Potential and 2 We Find Risky Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks…
Healthcare Technology for Providers Stocks Q2 Recap: Benchmarking Omnicell (NASDAQ:OMCL) As the craze of earnings season draws to a close, here's a look back at some of the most exciting (and some less so) results from Q2. Today, we are lo…
Healthcare Technology for Providers Stocks Q2 In Review: Astrana Health (NASDAQ:ASTH) Vs Peers Wrapping up Q2 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (…
Omnicell trades around US$33.17 after a mixed share price record, and the key issue now is whether that level lines up with the cash the business can generate over time. With the stock showing both long slumps and shorter rebounds, investo…
3 Reasons OMCL is Risky and 1 Stock to Buy Instead Omnicell has been treading water for the past six months, recording a small loss of 4.6% while holding steady at $32.74. The stock also fell short of the S&P 500's 16.4% gain during that p…
Tempus AI TEM shares rallied 14.9% in the last trading session to close at $80.36. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 14.2% ga…
On August 14, US Physical Therapy (NYSE:USPH) announced that Nchacha Etta will become the company's Executive Vice President and Chief Financial Officer, effective September 1. The move closes out a search that began after Jason Curtis ste…
1 Cash-Heavy Stock to Target This Week and 2 We Question A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsis…
Healthcare Technology for Providers Stocks Q2 Teardown: Privia Health (NASDAQ:PRVA) Vs The Rest Looking back on healthcare technology for providers stocks' Q2 earnings, we examine this quarter's best and worst performers, including Privia…
1 Cash-Producing Stock on Our Buy List and 2 We Ignore A company that generates cash isn't automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cash flow is valuable, but it'…
Integration brings serialized product verification and traceability directly into medication receiving workflows, intended to enable more efficient pharmacy operations without separate compliance processes. BOSTON, Sept. 3, 2026 /PRNewswir…
Integration brings serialized product verification and traceability directly into medication receiving workflows, intended to enable more efficient pharmacy operations without separate compliance processes. BOSTON, Sept. 3, 2026 /PRNewswir…
FORT WORTH, Texas, August 31, 2026--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, announced that it will present at the Wells Fargo 21st Annu…
3 Small-Cap Stocks We Approach with Caution Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small…
President & COO Nnamdi Njoku reported a sale of 6,753 shares of Omnicell, Inc. (NASDAQ:OMCL) at ~$37.09 per share on August 15, 2026, and August 17, 2026, according to a SEC Form 4 filing. Transaction summary Metric Value Transaction value…
HOUSTON, August 14, 2026--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services ("I…
Omnicell, Inc. OMCL raised its 2026 earnings outlook after a better-than-expected second quarter, but part of the profit improvement came from a one-time tariff refund. The next test is whether operating discipline can absorb higher memory…
Omnicell, Inc. OMCL shares have fallen 20.1% in the past four weeks, sharpening the debate over whether the pullback has improved the risk-reward setup or reflects pressures that may persist. The central tension is clear. Omnicell has rais…
In the past quarter, Omnicell, Inc. reported second-quarter 2026 revenue of US$312.21 million and net income of US$24.29 million, with both basic and diluted earnings per share from continuing operations rising compared with a year earlier…
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Omnicell stock is currently caught between two different valuation signals. The Discounted Cash F…
Omnicell, Inc. OMCL highlighted accelerating customer engagement around its next-generation medication management platforms during its second-quarter 2026 earnings call while noting that large customer decisions are taking longer to finali…
Omnicell (OMCL) Stock Trades Down, Here Is Why What Happened? Shares of healthcare tech company Omnicell (NASDAQ:OMCL) fell 9.9% in the afternoon session after the company issued weak guidance for the upcoming quarter that overshadowed its…
This article first appeared on GuruFocus. Release Date: July 30, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Solid Q2 2026 execution with total revenue of $312 m…
New solution may help pharmacies grow monthly vaccinations by up to 66%1 FORT WORTH, Texas, July 30, 2026--(BUSINESS WIRE)--EnlivenHealth, Inc., a subsidiary of Omnicell, Inc. ("EnlivenHealth") and a leading innovator in pharmacy technolog…
Earnings Call Insights: Omnicell (OMCL) Q2 2026 MANAGEMENT VIEW * "We delivered solid execution in the second quarter with results at or above our expectations across key financial metrics" (Founder, Executive Chairman & CEO Randall Lipps)…
Omnicell (OMCL) came out with quarterly earnings of $0.94 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.45 per share a year ago. These figures are adjusted for non-recurring items. This…
Omnicell's (NASDAQ:OMCL) Q2 CY2026: Beats On Revenue But Stock Drops On Weak Guidance Healthcare tech company Omnicell (NASDAQ:OMCL) beat Wall Street's revenue expectations in Q2 CY2026, with sales up 7.4% year on year to $312.2 million. O…
Omnicell delivers solid second quarter 2026 financial results Updates full year 2026 guidance FORT WORTH, Texas, July 30, 2026--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," or the "Company"), a leading healthcare…
Omnicell (OMCL) Reports Q2: Everything You Need To Know Ahead Of Earnings Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Thursday morning. Here's what investors should know. Omnicell beat analysts'…
2 Cash-Heavy Stocks to Target This Week and 1 We Turn Down Companies with more cash than debt can be financially resilient, but that doesn't mean they're all strong investments. Some lack leverage because they struggle to grow or generate…
Omnicell OMCL is set to release second-quarter 2026 results on July 30, before market open. In the last reported quarter, the company posted adjusted earnings per share (EPS) of 55 cents, which surpassed the Zacks Consensus Estimate by 66.…
1 Healthcare Stock to Target This Week and 2 We Brush Off Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have…
Earlier this month, Omnicell filed a US$72.384 million shelf registration for 1,600,000 common shares tied to an ESOP-related offering and elevated Chief Operating Officer Nnamdi Njoku to President, while Randall Lipps remained Chief Execu…
FORT WORTH, Texas, July 13, 2026--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results for the second quarter 202…